Patients in which no LOH was observed at any microsatellite markers | Patients in which LOH was observed at one or more microsatellite markers | |||||
---|---|---|---|---|---|---|
No. | % | No. | % | Pvaluee | ||
R a | 11/15 | 73.3% | R a | 20/36 | 55.56% | 0.35 |
N b | 4/15 | 26.7% | N b | 16/36 | 44.44% | |
Tumour Grade 1.2 | 15/19 | 78.9% | Tumour Grade 1.2 | 30/44 | 68.18% | 0.55 |
Tumour Grade 3 | 4/19 | 21.1% | Tumour Grade 3 | 14/44 | 31.82% | |
LNMc+ | 13/19 | 68.4% | LNMc+ | 22/45 | 48.89% | 0.25 |
LNMd– | 6/19 | 31.6% | LNMd– | 23/45 | 51.11% | |
Tumour Size (<3 cm) | 8/17 | 47.1% | Tumour Size (<3 cm) | 22/45 | 48.89% | 0.88 |
Tumour Size (>3 cm) | 9/17 | 52.9% | Tumour Size (>3 cm) | 23/45 | 51.11% |